[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339524-105":59,"doc-detail-339524-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-comprehensive-validation-of-a-predictive-prognosis-model-for-very-early-hcc-recurrence-within-one-year-after-curative-resection-multicenter-cohort-study","Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection - multicenter cohort study","","Hepatocellular carcinoma has a high incidence of early recurrence after liver resection, which limits long-term survival. A multicenter study aimed to develop a prognostic model to predict very early (1-year) recurrence risk after curative resection. The VERM-pre model was derived from Chinese multicenter patients and validated using internal and external retrospective cohorts and a separate prospective two-center cohort. Key variables included tumor diameter, tumor number, macrovascular invasion, satellite nodules, AFP, HBV-DNA, γ-GT, and prothrombin time, yielding strong discrimination and calibrated risk strata.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-comprehensive-validation-of-a-predictive-prognosis-model-for-very-early-hcc-recurrence-within-one-year-after-curative-resection-multicenter-cohort-study/339524/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-comprehensive-validation-of-a-predictive-prognosis-model-for-very-early-hcc-recurrence-within-one-year-after-curative-resection-multicenter-cohort-study/339524.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What study objective was addressed in this research?","Question",{"text":112,"@type":113},"To develop a prognostic model that predicts the risk of very early (1-year) recurrence of hepatocellular carcinoma after curative liver resection, and to validate it comprehensively.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the VERM-pre model developed and validated?",{"text":117,"@type":113},"It was derived from consecutive curative-intent liver resection patients across multicenters in China, then validated using internal and external retrospective cohorts and another two-center cohort prospectively.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were identified as independent risk factors for recurrence-free survival?",{"text":121,"@type":113},"Eight variables: tumor diameter, tumor number, macrovascular invasion, satellite nodule, alpha-fetoprotein, HBV-DNA level, γ-GT, and prothrombin time.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339524,1790915299,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","’Prospective Cohort Study  \nDevelopment and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection:  \na multicenter cohort study  \nLei Liu, MDa , Shangdong Qin, MMb , Kongying Lin, MDc , Qingguo Xu, MDd , Yuan Yang, MDa , Jinzhen Cai, MDd , Yongyi Zeng, MDc , Shengxian Yuan, MDa,* , Bangde Xiang, MDb,* , Wan Yee Lau, MDa,e,* , Weiping Zhou, MDa,f,g,*  \nBackground: The high incidence of early recurrence after liver resection (LR) for hepatocellular carcinoma (HCC) is the main obstacle in achieving good long-term survival outcomes. The aim of the present study is to develop a prognostic model in predicting the risk of very early (1-year) recurrence.  \nMaterial and methods: Consecutive patients who underwent LR for HCC with curative intent at multicenters in China were enrolled in this study. The VERM-pre (the Preoperative Very Early Recurrence Model of HCC) with good performance was derived and validated by internal and external cohorts retrospectively and by another two-center cohort prospectively.  \nResults: Seven thousand four hundred one patients were enrolled and divided randomly into three cohorts. Eight variables (tumor diameter, tumor number, macrovascular invasion, satellite nodule, alpha-fetoprotein, level of HBV-DNA, γ-GT, and prothrombin time) were identiﬁed as independent risk factors for recurrence-free survival on univariate and multivariate analyses. The VERM-pre model was developed which showed a high capacity of discrimination (C-index: 0.722; AUROC at 1-year: 0.722)) and was validated comprehensively by the internal, external, and prospective cohorts, retrospectively. Calibration plots showed satisfactory ﬁtting of probability of early HCC recurrence in the cohorts. Three risk strata were derived to have signiﬁcantly different recurrence-free survival rates (low-risk: 80 .4–85.4%; intermediate-risk: 59 .7–64.8%; high-risk: 32 .6–42.6%) . In the prospective validation cohort, the swimming plot illustrated consistent outcomes with the beginning predictive score.  \nConclusion: TheVERM-pre model accurately predicted the 1-year recurrence rates of HCC after LR with curative intent. The model was retrospectively and prospectively validated and then developed as the online tool.  \nKeywords: early recurrence, hepatocellular carcinoma, liver resection, prognostic predictive score  \nIntroduction  \nHepatocellular carcinoma (HCC) is a major cause of cancerrelated death in the world and nearly half of new cases each year occurs in China[1,2] . Currently liver resection (LR) is still a commonly recommended treatment option for very early and early  \nstages of HCC based on the BCLC staging[2,3] and the American Joint Committee on Cancer (AJCC) Tumor-Node-Metastasis (TNM) systems[4,5] . However, postoperative recurrence of HCC after LR is still high[6] . Previous studies have conﬁrmed tumor recurrence within 1-year after LR as an independent risk factor for poor overall survival (OS)[7–10] probably because  \naThe Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, bHepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, cDepartment of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, dOrgan Transplantation Center, The Institute of Transplantation Science, The Afﬁliated Hospital of Qingdao University, eFaculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, fKey Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer (SMMU), Ministry of Education and gShanghai Key Laboratory of Hepatobiliary Tumor Biology (EHBH), Shanghai, People ’s Republic of China  \nLei Liu, Shangdong Qin, Kongying Lin, and Qingguo Xu share the co-ﬁrst authorship.  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding author. Address: The Third Depa","cbCaibEzunWXbhyB","https://ap.wps.com/l/cbCaibEzunWXbhyB","pdf",1599506,11,"English","# Background\n# Material and methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What study objective was addressed in this research?\",\"answer\":\"To develop a prognostic model that predicts the risk of very early (1-year) recurrence of hepatocellular carcinoma after curative liver resection, and to validate it comprehensively.\"},{\"question\":\"How was the VERM-pre model developed and validated?\",\"answer\":\"It was derived from consecutive curative-intent liver resection patients across multicenters in China, then validated using internal and external retrospective cohorts and another two-center cohort prospectively.\"},{\"question\":\"Which factors were identified as independent risk factors for recurrence-free survival?\",\"answer\":\"Eight variables: tumor diameter, tumor number, macrovascular invasion, satellite nodule, alpha-fetoprotein, HBV-DNA level, γ-GT, and prothrombin time.\"}]","Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection - multicenter cohort study | PDF",1790030835,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a254d7fd6b04857771d83f010c6251f3.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/113ed10930fc24de8a45c1c48146c9c3.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/070d712c8b391ae07359aa063b401d51.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84632908f32d7a9828557ba5f2669787.webp",980,1306]